Publicaciones en colaboración con investigadores/as de Instituto de Salud Carlos III (20)

2012

  1. Comparative in vitro activity of common antibiotics and relationship with changes in Streptococcus pneumoniae serotypes causing otitis in children prior to and 10 years after introduction of conjugate vaccines in Spain

    International Journal of Antimicrobial Agents

  2. Variations in serotypes and susceptibility of adult non-invasive Streptococcus pneumoniae isolates between the periods before (May 2000-May 2001) and 10 years after (May 2010-May 2011) introduction of conjugate vaccines for child immunisation in Spain

    International Journal of Antimicrobial Agents, Vol. 40, Núm. 1, pp. 18-23

2011

  1. Evolution of clonal and susceptibility profiles of serotype 19A Streptococcus pneumoniae among invasive isolates from children in Spain, 1990 to 2008

    Antimicrobial Agents and Chemotherapy, Vol. 55, Núm. 5, pp. 2297-2302

  2. Increase in serotype 19A prevalence and amoxicillin non-susceptibility among paediatric Streptococcus pneumoniae isolates from middle ear fluid in a passive laboratory-based surveillance in Spain, 1997-2009

    BMC Infectious Diseases, Vol. 11

2010

  1. Serotype distribution and susceptibility of Streptococcus pneumoniae isolates from pleural fluid in Spain from 1997 to 2008

    Antimicrobial Agents and Chemotherapy, Vol. 54, Núm. 12, pp. 5387-5390

  2. Susceptibility of recently collected spanish pneumococci nonsusceptible to oral penicillin from serotypes not included in the 7-valent conjugate vaccine

    Antimicrobial Agents and Chemotherapy, Vol. 54, Núm. 6, pp. 2696-2698

2009

  1. Susceptibility of pneumococci causing meningitis in Spain and prevalence among such isolates of serotypes contained in the 7-valent pneumococcal conjugate vaccine

    Journal of Antimicrobial Chemotherapy

2008

  1. Breakthrough in penicillin resistance? Streptococcus pneumoniae isolates with penicillin/cefotaxime MICs of 16 mg/L and their genotypic and geographical relatedness

    Journal of Antimicrobial Chemotherapy, Vol. 62, Núm. 6, pp. 1234-1240

  2. Has the licensing of respiratory quinolones for adults and the 7-valent pneumococcal conjugate vaccine (PCV-7) for children had herd effects with respect to antimicrobial non-susceptibility in invasive Streptococcus pneumoniae?

    Journal of Antimicrobial Chemotherapy, Vol. 62, Núm. 6, pp. 1430-1433

  3. High protein binding and cidal activity against penicillin-resistant S. pneumoniae: A cefditoren in vitro pharmacodynamic simulation

    PLoS ONE, Vol. 3, Núm. 7

  4. In vitro activity of ME1036 versus other β-lactams against penicillin-resistant Streptococcus pneumoniae serotypes exhibiting higher amoxicillin than penicillin MIC

    Journal of Antimicrobial Chemotherapy

  5. In vitro activity of ceftaroline against Streptococcus pneumoniae isolates exhibiting resistance to penicillin, amoxicillin, and cefotaxime

    Antimicrobial Agents and Chemotherapy

  6. In vitro activity of oral cephalosporins against pediatric isolates of Streptococcus pneumoniae non-susceptible to penicillin, amoxicillin or erythromycin

    Journal of Chemotherapy, Vol. 20, Núm. 2, pp. 175-179

  7. Influence of penicillin/amoxicillin non-susceptibility on the activity of third-generation cephalosporins against Streptococcus pneumoniae

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 27, Núm. 1, pp. 75-80

2007

  1. Activity of cefditoren against clinical isolates of Streptococcus pneumoniae showing non-susceptibility to penicillins, cephalosporins, macrolides, ketolides or quinolones

    International Journal of Antimicrobial Agents

  2. Influence of the β-lactam resistance phenotype on the cefuroxime versus cefditoren susceptibility of Streptococcus pneumoniae and Haemophilus influenzae recovered from children with acute otitis media

    Journal of Antimicrobial Chemotherapy, Vol. 60, Núm. 2, pp. 323-327

2006

  1. Actividad de cefpodoxima y otros betalactámicos orales frente a Haemophilus influenzae y Streptococcus pneumoniae con distinta sensibilidad a la penicilina

    Revista Espanola de Quimioterapia, Vol. 19, Núm. 1, pp. 39-44

2005

  1. Effect of opsonophagocytosis mediated by specific antibodies on the co-amoxiclav serum bactericidal activity against Streptococcus pneumoniae after administration of a single oral dose of pharmacokinetically enhanced 2000/125 mg co-amoxiclav to healthy volunteers

    Journal of Antimicrobial Chemotherapy, Vol. 55, Núm. 5, pp. 742-747

2001

  1. In vitro susceptibility of Neisseria meningitidis isolates to gemifloxacin and ten other antimicrobial agents

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 20, Núm. 2, pp. 150-151

2000

  1. In vitro activities of gemifloxacin versus five quinolones and two macrolides against 271 Spanish isolates of Legionella pneumophila: Influence of charcoal on susceptibility test results

    Antimicrobial Agents and Chemotherapy, Vol. 44, Núm. 8, pp. 2176-2178